ArticleFrontiers in public health2025
Sarcopenia prediction model based on machine learning and SHAP values for community-based older adults with cardiovascular disease in China.
Article in Frontiers in public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Machine learning prediction models for visual impairment in Chinese adults aged ≥ 45 years with cardiovascular metabolic diseases: a population-based study using CHARLS.BMC ophthalmology · 2025Article
- Hierarchical Evaluation of Predictive Models for Confirmed Sarcopenia: Discrimination, Calibration, and Clinical Applicability in a Cross-Sectional Study of Older Adults.Journal of clinical medicine · 2025Article
- Anthropometric Measurements for Predicting Low Appendicular Lean Mass Index for the Diagnosis of Sarcopenia: A Machine Learning Model.Journal of functional morphology and kinesiology · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Sarcopenia (SP), is recognized as a complication of cardiovascular disease (CVD), but few relevant diagnostic models have been developed. This study aims to establish an interpretable diagnostic model for the occurrence of SP in older adult CVD patients living in Chinese community-dwelling (CD). Methods: We randomly selected participants with CVD recruited from CHARLS from 2011 to 2015 and divided them into a training set and a test set. In the training set, we processed and screened the predictor variables and addressed the data imbalance by the synthetic minority oversampling technique (SMOTE). Subsequently, we built four machine learning (ML) models to predict SP. After 100 iterations, we selected the best performing model for risk stratification by comparing model discrimination and calibration. Then, we analyzed the relationship between ML risk and SP using scatterplots and logistic regression (LR). Finally, the Shapley's Additive Explanatory Plot (SHAP) illustrates how each feature level affects the predicted probability of SP. Results: We ultimately included 1,088 CD older adults, 18.61% of whom reported SP. The optimal model, XGBoost, was selected for prediction and risk stratification. After both univariate (odds ratio [OR]: 12.45, Conclusion: This study develops a novel clinically-integrated tool that can be used to easily predict SP in the older adults population with CVD, providing a basis for the development of personalized therapeutic measures.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.